Peredo Ana P, Jo Yun Kee, Duan Gang, Dodge George R, Lee Daeyeon, Mauck Robert L
Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, 19104, USA; McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA; Translational Musculoskeletal Research Center, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, 19104, USA.
Department of Chemical and Biomolecular Engineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, 19104, USA; Department of Biomedical Convergence Science and Technology, Kyungpook National University, Daegu, 41566, South Korea.
Biomaterials. 2021 Jan;265:120255. doi: 10.1016/j.biomaterials.2020.120255. Epub 2020 Oct 10.
Although mechanical loads are integral for musculoskeletal tissue homeostasis, overloading and traumatic events can result in tissue injury. Conventional drug delivery approaches for musculoskeletal tissue repair employ localized drug injections. However, rapid drug clearance and inadequate synchronization of molecule provision with healing progression render these methods ineffective. To overcome this, a programmable mechanoresponsive drug delivery system was developed that utilizes the mechanical environment of the tissue during rehabilitation (for example, during cartilage repair) to trigger biomolecule provision. For this, a suite of mechanically-activated microcapsules (MAMCs) with different rupture profiles was generated in a single fabrication batch via osmotic annealing of double emulsions. MAMC physical dimensions were found to dictate mechano-activation in 2D and 3D environments and their stability in vitro and in vivo, demonstrating the tunability of this system. In models of cartilage regeneration, MAMCs did not interfere with tissue growth and activated depending on the mechanical properties of the regenerating tissue. Finally, biologically active anti-inflammatory agents were encapsulated and released from MAMCs, which counteracted degradative cues and prevented the loss of matrix in living tissue environments. This unique technology has tremendous potential for implementation across a wide array of musculoskeletal conditions for enhanced repair of load-bearing tissues.
尽管机械负荷对于肌肉骨骼组织的稳态不可或缺,但过载和创伤事件可能导致组织损伤。用于肌肉骨骼组织修复的传统药物递送方法采用局部药物注射。然而,药物快速清除以及分子供应与愈合进程的同步性不足使得这些方法无效。为克服这一问题,开发了一种可编程的机械响应性药物递送系统,该系统利用康复过程中(例如软骨修复期间)组织的机械环境来触发生物分子的供应。为此,通过双乳液的渗透退火在单个制造批次中生成了一组具有不同破裂特性的机械激活微胶囊(MAMC)。发现MAMC的物理尺寸决定了其在二维和三维环境中的机械激活以及它们在体外和体内的稳定性,证明了该系统的可调性。在软骨再生模型中,MAMC不会干扰组织生长,并根据再生组织的机械特性而激活。最后,生物活性抗炎剂被封装在MAMC中并从中释放,其抵消了降解信号并防止了活组织环境中基质的损失。这项独特的技术在广泛的肌肉骨骼疾病中具有巨大的应用潜力,可增强承重组织的修复。